Distribution and effects of PACAP, VIP, nitric oxide and GABA in the gut of the African clawed frog Xenopus laevis
Department of Zoophysiology, Göteborg University, Box 463, S-405 30 Göteborg, Sweden
e-mail: c.olsson{at}zool.gu.se
Accepted 28 January 2002
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: amphibian, immunohistochemistry, gut motility, enteric nervous system, VIP, PACAP, nitric oxide, GABA, Xenopus laevis
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The aim of this study was to investigate the distribution of members of the VIP/GRF-family, nitric oxide and GABA, and their possible roles as inhibitory neurotransmitters in the amphibian gut. In addition, the results obtained are compared with data from other groups of vertebrates. The African clawed frog, Xenopus laevis, is widely used as a model animal in studies of genetics and ontogeny, including the development of autonomic innervation. However, little is known about the distribution of neurotransmitters in the adult animal. Therefore, Xenopus laevis was chosen as a representative of the amphibians.
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate
cyclase-activating polypeptide (PACAP) are two neuropeptides belonging to the
same gene superfamily, the VIP/GRF-family. The sequences of both peptides have
been determined in several different vertebrate species, including amphibians
(Hoyle, 1998). PACAP usually
exists in two C-terminally amidated isoforms, one form containing 27 amino
acids (PACAP 27) and one C-terminally extended (PACAP 38). The sequence of
PACAP has been well conserved during evolution; the amphibian (Rana
ridibunda) sequence, for example, differs in only one position compared
with the mammalian PACAP (Chartrel et al.,
1991
; Hoyle,
1998
). Since this substitution occurs in the C-terminal region,
PACAP 27 is identical in mammals and in this amphibian. The amphibian VIP
shows 86 % identity to the mammalian VIP sequence and there is 75 % amino acid
sequence identity between the amphibian VIP and PACAP (1-28)
(Hoyle, 1998
). Helospectin,
another member of this gene family, has been isolated from the venom of the
lizards Heloderma suspectum and H. horridum, and exists in
two forms consisting of 37 and 38 amino acids, respectively
(Parker et al., 1984
). VIP has
been found in the enteric nervous system in species from all vertebrate
classes (Jensen and Holmgren,
1994
) while the distribution of PACAP and helospectin is less
investigated. In rainbow trout (Oncorhynchus mykiss) and Atlantic cod
(Gadus morhua), as well as in some mammals, VIP, PACAP and
helospectin are colocalised to a high degree in enteric nerve cells
(Absood et al., 1992
;
Olsson and Holmgren, 1994
;
Sundler et al., 1992
).
Nitric oxide can be synthesised by reduction of L-arginine to L-citrulline,
a reaction carried out by the enzyme nitric oxide synthase (NOS). NOS exists
in several isoforms including one nerve-specific isoform that can be
demonstrated by using either immunohistochemistry or NADPH-diaphorase
histochemistry (see Lincoln et al.,
1997). Neuronal NOS is widely distributed in the enteric nervous
system of most vertebrate species examined including one amphibian species,
Bufo marinus (Costa et al.,
1992
; Ward et al.,
1992
; Li et al.,
1992
; Olsson and Karila,
1995
; Timmermans et al.,
1994
). Frequently, a subpopulation of NOS-positive neurons
coexpress VIP and/or PACAP (Costa et al.,
1992
; Li et al.,
1993
; Olsson and Karila,
1995
).
In mammals, PACAP, VIP and nitric oxide usually inhibit gastrointestinal
motility. Since these transmitters could be found within the same nerve cells,
it has been suggested that they interact with each other in mediating this
response. Several studies have shown that the release of VIP is facilitated by
nitric oxide (Grider, 1993;
Grider and Jin, 1993
;
Daniel et al., 1994
;
Grider et al., 1994
). It has
also been indicated that VIP stimulates nitric oxide production in some
tissues (Li and Rand, 1990
;
Grider, 1993
;
Jin et al., 1993
;
Grider et al., 1994
) although
other groups could see no such effects
(D'Amato et al., 1992
;
Grider and Jin, 1993
;
Ekblad and Sundler, 1997
).
GABA (-amino-butyric acid) is an important inhibitory
neurotransmitter in the central nervous system but has also been demonstrated
in enteric neurons in several species, including frog
(Hills et al., 1987
;
Furness et al., 1989
;
Gabriel and Eckert, 1989
;
Williamson et al., 1996
;
Wu et al., 1998
). In the
guinea-pig intestine, GABAergic neurons frequently coexpress NOS and/or VIP
immunoreactivities, and a few fibres are substance P-immunoreactive
(Nichols et al., 1995
;
Williamson et al., 1996
). Most
GABAergic enteric neurons act as interneurons and the effect on
gastrointestinal motility is usually inhibitory
(Grider and Makhlouf, 1992
;
Minocha and Galligan, 1993
).
In addition, GABA can stimulate the release of acetylcholine, causing
contractions of the smooth muscles
(Krantis et al., 1980
;
Grider and Makhlouf, 1992
;
Minocha and Galligan,
1993
).
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Before the experiments the animals were anaesthetised by immersion in carbonate-buffered tap water containing 0.1 % MS 222 (3-aminobenzoic acid ethyl ester; Sigma) and killed by decapitation.
Immunohistochemistry
Tissues were collected from seven regions of the gastrointestinal tract:
the cardiac stomach, the pyloric stomach, the proximal small intestine
(duodenum), the middle small intestine (upper ileum), the distal small
intestine (lower ileum), the large intestine (colon and rectum) and the
cloaca. The preparations were immersed in phosphate-buffered saline (PBS; 0.1
mol l-1 sodium phosphate, 0.9 % NaCl, pH 7.2) containing the
smooth-muscle relaxant nifedipine (10-5 mol l-1; Sigma)
and then stretched and pinned onto dental wax. The tissue was fixed for 4 h in
4 % formaldehyde in 0.1 mol l-1 phosphate buffer (PB; pH 7.0) at 4
°C and subsequently washed in PBS. Whole-mount preparations were prepared
by peeling off the mucosa, the submucosa and most of the circular muscle layer
exposing the myenteric plexus. Preparations used for sectioning were kept
overnight in PBS containing 30 % sucrose as cryprotectant before they were
frozen in isopentane pre-chilled in liquid N2 and cut into 10 µm
sections on a cryostat.
The preparations were incubated with normal donkey serum (1:10; Jackson Immuno Research, USA) for 30 min before incubation for 2 days at room temperature with the primary antisera. Usually, double staining was performed, meaning that a mixture of two antisera was used. These were directed against different antigens and raised in different host species (see Table 1 for details). The preparations were washed in PBS (2 % NaCl), incubated for 1 h with the appropriate secondary antisera conjugated to Cy3 (indocarbocyanine), DTAF (dichlorotriazinyl amino fluorescein) or biotin (Jackson Immuno Research, USA) and washed in PBS. The biotinylated antibodies were visualised by incubation with streptavidinCy3 complex (Jackson Immuno Research, USA) and finally washed in PBS. The preparations were mounted in carbonate-buffered glycerol and viewed with an Olympus fluorescence microscope. Normal serum and antisera were diluted with PBS (2 % NaCl) plus 0.1 % bovine serum albumin, 0.2 % NaN3 and 0.2 % Triton X-100, pH 7.2.
|
The specificity of the two VIP antisera was tested by preincubation with
excess amounts of VIP, PACAP 27, helospectin or secretin (10-5
moll-1 diluted antiserum). No crossreactivity with PACAP 27,
helospectin or secretin was seen with either antiserum, while all
immunoreactivity was abolished after preincubation with VIP. Likewise,
preincubation of the PACAP antiserum with PACAP 27 extinguished the
immunoreactivity while no crossreactivity with VIP was detected. Furthermore,
no immunoreactivity was found when the GABA antiserum was preabsorbed with
GABA (10-4 moll-1; Sigma) (for details, see
Furness et al., 1989).
The density (± S.D.) and size (± S.D.) of the NOS-immunoreactive nerve cells were determined using a x40 objective. The number of cells in 0.021 cm2 of each preparation was counted and a minimum of 25 nerve cells was measured in each preparation.
NADPH-diaphorase histochemistry
Whole mounts were prepared as above except that the fixation time was only
1 h. The preparations were incubated with a reaction medium containing 1 mg
ml-1 ß-NADPH (Sigma), 0.25 mg ml-1 nitroblue
tetrazolium (Sigma) and 0.1 % Triton X-100 in 0.1 moll-1 PB (pH
7.0). The reaction was carried out at 37°C during 1 h and stopped by
washing the preparation in PB.
For double staining, some preparations were incubated with NOS-antiserum prior to the NADPH/nitroblue tetrazolium mixture and finally visualised using Cy3-conjugated secondary antisera.
Pharmacological experiments
Circular strip preparations (approximately 2x10 mm), including the
muscle layers and the mucosa, were prepared from the cardiac stomach, and
similar longitudinal preparations were taken from the duodenum. All
preparations were mounted in organ baths containing 5 ml McKenzie's solution
(pH 7.9) (Lockwood, 1967) kept
at room temperature and bubbled with 0.3 % CO2 in air. The force
developed by the smooth muscle preparations (which reflects the tension in the
preparations) was recorded via an FT03 isometric force transducer and
a Grass Model 7 polygraph, and simultaneously sampled on data-acquisition
software (AD/DATA; P. Thorén, Karolinska Institute, Stockholm, Sweden).
The sampling frequency was set to one sample s-1 and the mean
values of 10 samples were calculated and stored. An initial force of 10 mN was
applied to the preparations, which were left to recover for at least 1 h,
until they had adopted a stable resting tension. During the recovery period,
most preparations began to exhibit rhythmic contractions.
The following drugs were used: mammalian PACAP 27 (10-7 moll-1; Peninsula, UK), mammalian VIP (10-7-10-6 moll-1; Auspep, Australia), GABA (10-7-10-4 moll-1), the nitric oxide donor sodium nitroprusside (NaNP; 10-7-10-6 moll-1) and the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 3x10-4 moll-1) (all Sigma).
The results are presented as the mean force developed (± S.E.M.). To normalise the sampled values, the resting tension (i.e. the tension level adopted by the preparations between spontaneous contractions) of the corresponding control period was subtracted from each data point in all experiments. Negative values indicate a reduction in resting tension, i.e. relaxation, caused by the treatment. The mean force developed during 5 min immediately before addition of the drug was compared with a 3 min (stomach) or 5 min (intestine) period after the full effect of the drug was reached or, when no apparent effect was achieved, after approximately 5 min. Wilcoxon matched-pairs, signed-ranks test was used for statistical evaluation of the results. Differences where P<0.05 were regarded as statistically significant.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A high number of PACAP-immunoreactive nerve fibres occurred in all layers of the gut wall in all regions examined (Figs 1, 2). Numerous varicose fibres ran in nerve bundles in the myenteric plexus and parallel to the muscle fibres. Weakly PACAP-immunoreactive nerve cell bodies were seen in the myenteric plexus (Fig. 1C). In addition, PACAP immunoreactivity was found in endocrine cells in the mucosa (Fig. 1D).
|
|
Double labelling with PACAP and VIP (guinea pig) antisera showed a more or less complete colocalisation of the two neuropeptides in nerves (Fig. 2A-F) while no endocrine cells displayed any VIP immunoreactivity. In contrast, VIP-immunoreactive endocrine cells were demonstrated by an antiserum raised in rabbit. As mentioned in Materials and methods, preincubation of both VIP antisera with VIP quenched the immunoreactivity, including in the endocrine cells, while other members of the VIP family had no such effect. This suggests that these cells contain VIP or a very similar substance although this could not be detected using the guinea pig antiserum. Double labelling with VIP and helospectin antisera showed a high degree of colocalisation although the helospectin immunoreactivity in general was weaker (Fig. 2G-H).
Numerous NOS-immunoreactive or NADPH-diaphorase reactive nerve cell bodies were found in the myenteric plexus all along the gastrointestinal tract except in the cloaca (Fig. 3). Double staining demonstrated that the same nerve cells were stained with the two methods. Varicose nerve fibres were seen with both methods but were most intensely stained by the NADPH-diaphorase method (Fig. 3I). The NOS-reactive nerve cells were usually located in close association with nerve bundles (Fig. 3A,F,H,I) and most common in the middle intestine (Table 2). The average density for the whole gut was 4584±540 cells cm-2 (N=3, n=457 cells). A majority of the nerve cells were multipolar with an average soma size of 11.3±3.7 x 23.2±6.6 µm (Table 2). Sections showed NOS-immunoreactive nerve fibres in both muscles layers, in the submucosa and the mucosa and in endocrine cells in the intestinal mucosa (Fig. 3C,D).
|
|
Double staining of the preparations showed partial overlap between NOS- and VIP-immunoreactive nerve fibres (Fig. 3). The degree of colocalisation was most easily observed in the muscle layers where a majority of NOS-positive nerve fibres were VIP-immunoreactive (Fig. 3D,E). The overall density of VIP-immunoreactive fibres was higher compared to the density of NOS-positive fibres, indicating a large number of NOS-negative VIP-immunoreactive fibres (Fig. 3A,B,F,G). There was also colocalisation in some nerve cell bodies, but due to weak staining of cell bodies with the VIP antiserum, no quantification was done.
The antiserum against GABA revealed nerve fibres and/or nerve cell bodies in the myenteric plexus in all regions examined (Fig. 4). GABA-immunoreactive nerve fibres were frequent in the submucosa and myenteric plexus and some were seen in the muscle layers. In the myenteric plexus, the vast majority of GABA-immunoreactive nerve fibres did not express VIP immunoreactivity (Fig. 4C,D), while in the submucosa, the number of fibres showing colocalisation of GABA and VIP was higher, although still less than 50 %. The GABA-immunoreactive nerve cell bodies were small, usually bipolar, or larger and multipolar. In the rectum, which showed a well developed network of GABA-immunoreactive nerve fibres (Fig. 4B,C), the number of immunoreactive nerve cell bodies was low, and no nerve cell bodies were seen in the cloaca.
|
Pharmacological experiments
The circular preparations of the cardiac stomach usually developed
spontaneous contractions with varying amplitude and frequency
(Fig. 5). PACAP 27, VIP, NaNP
and GABA had similar effects on the gastric motility and reduced the mean
force developed, mainly by lowering the resting tension, while not necessarily
affecting the frequency or amplitude of the contractions
(Fig. 5). PACAP 27
(10-7 mol l-1) reduced the mean force developed from
0.65±0.17 mN to -0.42±0.26 mN (N=8) while VIP
(10-7 or 10-6 mol l-1) lowered the mean force
developed from 0.39±0.07 mN to -0.34±0.16 mN and
-0.73±0.18 mN (N=6), respectively
(Fig. 6). The nitric oxide
donor NaNP (10-7 or 10-6 mol l-1) caused a
reduction in mean force developed from 0.49±0.15 mN to
-0.44±0.31 mN (N=6) and -1.06±0.25 mN (N=8)
(Fig. 7). GABA had no effect at
the lowest concentration tested (10-7 mol l-1) but
reduced the mean force developed from 0.63±0.17 mN to 0.05±0.21
mN at 10-6 mol l-1 and to -0.48±0.20 mN at
10-5 mol l-1 (N=6). No further reduction was
seen at 10-4 mol l-1 (N=6)
(Fig. 6). The L-arginine
analogue L-NAME, increased the mean force developed from 0.46±0.09 mN
to 1.15±0.37 mN (N=6), indicating a tonic release of
inhibitory nitric oxide (Fig.
7). The increase in mean force was mainly due to an increase in
amplitude of the spontaneous contractions.
|
|
|
The longitudinal preparations of the proximal small intestine usually developed spontaneous contractions that were more regular, with larger amplitudes, compared to the stomach. PACAP 27, VIP, NaNP, GABA and L-NAME had no significant effect on the motility of these intestinal preparations (Figs 8, 9).
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PACAP immunoreactivity has been demonstrated throughout the
gastrointestinal tract in several mammals as well as in the Atlantic cod and
the rainbow trout (Sundler et al.,
1992; Olsson and Holmgren,
1994
). The distribution in X. laevis is in good
agreement with these previous studies, with a dense PACAP innervation of the
longitudinal and the circular muscle layers and the mucosa. The degree of
colocalisation of PACAP and VIP varies somewhat between species. In X.
laevis, as in cod, rainbow trout, chicken and human, the two
immunoreactivities overlap to approximately 100%
(Sundler et al., 1992
;
Olsson and Holmgren, 1994
). In
contrast, in several other mammals the two peptides exist in separate nerve
populations (Sundler et al.,
1992
). VIP and helospectin immunoreactivities are colocalised in
enteric nerves in most species investigated
(Absood et al., 1992
;
Olsson and Holmgren, 1994
).
Since the staining of VIP/PACAP/helospectin immunoreactive nerve cells bodies
was weak in X. laevis, no quantification of the density of cells was
done. The antiserum against VIP used in double-staining experiments did not
reveal any endocrine cells, making it impossible to investigate any
colocalisation of VIP and PACAP or VIP and helospectin in endocrine cells. In
mammals, no PACAP-immunoreactive endocrine cells have been demonstrated,
whereas they are common in chicken and fish
(Sundler et al., 1992
;
Olsson and Holmgren, 1994
). In
the cod and the rainbow trout, these cells also contain VIP
(Olsson and Holmgren, 1994
).
Helospectin-immunoreactive endocrine cells are found in mammals as well as in
fish, but only the latter coexpress VIP. In summary, the distribution of VIP-,
PACAP- and helospectin immunoreactivities in the enteric nervous system of
X. laevis is similar to the patterns found in most other vertebrates
(Buchan, 1986
;
Absood et al., 1992
;
Sundler et al., 1992
;
Olsson and Holmgren, 1994
),
indicating similar functions in different species.
The density of NOS-immunoreactive nerve cell bodies has been determined in
several vertebrates (Li et al.,
1992,
1994
;
Timmermans et al., 1994
;
Olsson and Karila, 1995
). The
present data show that the number of cells in the gastrointestinal tract of
X. laevis is within the same range but the regional distribution may
vary somewhat. A subpopulation of the NOS-immunoreactive nerve fibres were
VIP-immunoreactive, but not all VIP-positive fibres were NOS-immunoreactive,
which indicates the presence of three different neuronal subpopulations in
X. laevis: one containing VIP/PACAP/helospectin/NOS, one containing
VIP/PACAP/helospectin and one containing NOS. The same three populations are
found in many species investigated although the relative number of each
population may vary (Costa et al.,
1992
; Aimi et al.,
1993
; Li et al.,
1993
; Olsson and Karila,
1995
; Olsson and Gibbins,
1999
). While characterising several classes of descending and
ascending myenteric neurons, Costa et al.
(1996
) demonstrated that VIP
and NOS are found in both inter- and motorneurons. In the toad Bufo
marinus, a majority of the VIP-immunoreactive nerve fibres were
NOS-immunoreactive as well (Li et al.,
1993
) and VIP- and NOS-containing nerves project anally in the
toad intestine, indicating an inhibitory function
(Murphy et al., 1993
).
GABA-immunoreactive nerve fibres, in addition to a low number of nerve cell
bodies, have previously been described within the amphibian stomach
(Gabriel and Eckert, 1989). In
the present study, GABA immunoreactivity was demonstrated in nerves in all
regions of the gut. In most regions, GABA-immunoreactive nerve cell bodies
were common. Similar to porcine enteric neurons, both multipolar and bipolar
cells are found in frog (this study;
Gabriel and Eckert, 1989
;
Wu et al., 1998
).
Few studies concerning the control of gastrointestinal motility have been
performed on X. laevis or other amphibians. Since the investigated,
presumed neurotransmitters were common in the enteric nervous system of X.
laevis, and had a distribution similar to other vertebrates, their
effects on the stomach and intestine motility were examined. PACAP, VIP,
nitric oxide and GABA all reduced the mean force developed by the circular
muscles of the cardiac stomach, while giving inconsistent responses in the
longitudinal preparations of the duodenum. The lack of an inhibitory effect on
the intestine contrasts with findings in the Atlantic cod where PACAP and
nitric oxide abolished the spontaneous contractions
(Olsson and Holmgren, 2000).
Previous studies have demonstrated that the rhythmic activity in the
gastrointestinal tract of amphibians involves interstitial cells of Cajal
located in the longitudinal muscle layer or in the myenteric plexus
(Prosser, 1995
). The rhythmic
activity of the stomach and intestine in X. laevis is not affected by
TTX (Å. Johansson and S. Holmgren, unpublished observations), indicating
that the contractions are not dependent on enteric nerves. In cod, however,
atropine abolished the contractions, demonstrating the presence of a
cholinergic tone necessary for maintaining the spontaneous contractions
(Olsson and Holmgren,
2000
).
In mammals, the effect of PACAP and VIP on gastrointestinal motility is
mediated mainly via VPAC1 and VPAC2 receptors,
which stimulate adenylate cyclase and thereby raise the levels of cAMP
(Harmar et al., 1998).
Recently, a VIP/PACAP receptor has been cloned from the frog Rana
ridibunda and it has also been demonstrated in the gastrointestinal
tract. This receptor shows characteristics of both mammalian VPAC1
and VPAC2 receptors and it has been speculated that amphibians
possess only one single receptor form
(Alexandre et al., 1999
). When
the VPAC receptor was expressed in mammalian cells, VIP and PACAP were equally
potent in stimulating cAMP production
(Alexandre et al., 1999
).
Although no further characterisations of the receptor were carried out in the
present study, it is likely that at least part of the effect of VIP and PACAP
on gastric motility is mediated via a similar receptor. The lack of
effect on the intestine could be due to low concentrations of the receptor or
to a shift in affinity for the two peptides. Alexandre et al.
(1999
) showed that the
amphibian VPAC receptor were common in the stomach while only low levels where
detected in the intestine. Although so far only one type of VIP/PACAP receptor
has been identified in the amphibian gut, other subtypes may occur, exhibiting
slightly different affinities and effects on motor activity. For example,
there is evidence for a PAC1 (PACAP preferring) receptor in the
frog, but its presence in the gastrointestinal tract has not yet been
confirmed (Alexandre et al.,
1999
). Furthermore, the effect of PACAP and VIP (and similarly of
nitric oxide and GABA) on the intestine could be masked by the high amplitude
of the spontaneous contractions. The substances may also play a role in, for
example, secretion and absorption.
The inhibitory effect of GABA on gastrointestinal motility is usually
mediated via GABAA receptors (stimulatory) on inhibitory
neurons and/or GABAB receptors (inhibitory) on cholinergic neurons
(Grider and Makhlouf, 1992;
Minocha and Galligan, 1993
).
In addition, GABAA receptors on the cholinergic neurons stimulate
the release of acetylcholine, causing contractions of the smooth muscles
(Krantis et al., 1980
;
Grider and Makhlouf, 1992
;
Minocha and Galligan, 1993
).
The nature and distribution of GABA receptors need to be further investigated
before any conclusion can be drawn about how the effect of GABA is mediated in
Xenopus.
Several studies have investigated the interactions between different
inhibitory substances. For example, it has been shown that nitric oxide
facilitates the release of VIP in several tissues
(Grider, 1993;
Grider and Jin, 1993
;
Daniel et al., 1994
;
Grider et al., 1994
). Other
studies have demonstrated that the production of nitric oxide is stimulated by
VIP and/or GABA (Li and Rand,
1990
; Boeckxstaens et al.,
1991
; Grider,
1993
; Jin et al.,
1993
; Grider et al.,
1994
). Recently, Krantis and coworkers demonstrated that nitric
oxide is responsible for the spontaneous relaxation in the gastric antrum and
duodenum, and that VIP-, GABA- and ATP-induced relaxation are mediated by
nitric oxide (Glasgow et al.,
1998
; Krantis et al.,
1998
). In addition, VIP can stimulate the release of GABA.
However, in some studies no stimulatory effect of VIP/PACAP on the production
of nitric oxide could be demonstrated
(D'Amato et al., 1992
;
Ekblad and Sundler, 1997
). It
is probable that nitric oxide, VIP, PACAP and GABA cooperate in Xenopus
laevis as well, but more research is needed.
To conclude, this study shows the presence of some putative
neurotransmitters in enteric neurons in Xenopus laevis. The
distribution of PACAP, VIP, NOS and GABA is similar to the situation observed
in mammals as well as in some nonmammalian species including elasmobranchs,
teleosts, other amphibians and reptiles. Furthermore, it is the first report
of the inhibitory effect on gastrointestinal motility of these substances in
an amphibian, as PACAP, VIP, nitric oxide and GABA cause relaxation of the
cardiac stomach in Xenopus. The widespread distribution of PACAP,
VIP, NOS and GABA in different groups of vertebrates, in addition to the
similarities in effect on the gut smooth muscle, indicates that these
substances play an important role in the inhibitory control of gut motility.
These neurotransmitters, as well as some of their receptors, probably arose
early in the evolution of vertebrates, or even before that as there are
reports of NOS, for example, in invertebrate species
(Johansson and Carlberg,
1995). The structures and the effects and intracellular pathways
involved have been well preserved during this time. Although we did not see
any effect on the duodenum in our experiments this does not necessarily rule
out the possibility that PACAP, VIP, nitric oxide and/or GABA are involved in
the control of intestinal as well as gastric motility.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Absood, A., Chen, D. and Håkanson, R. (1992). Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides. Regul. Pept. 40,311 -322.[Medline]
Aimi, Y., Kimura, H., Kinoshita, T., Fujimura, M. and Vincent, S. R. (1993). Histochemical localization of nitric oxide synthase in the rat enteric nervous system. Neuroscience 53,553 -560.[Medline]
Alexandre, D., Anouar, Y., Jegou, S., Fournier, A. and Vaudry,
H. (1999). A cloned frog vasoactive intestinal
polypeptide/pituitary adenylate cyclaseactivating polypeptide receptor
exhibits pharmacological and tissue distribution characteristics of both VPAC1
and VPAC2 receptors in mammals. Endocrinology
140,1285
-1293.
Boeckxstaens, G. E., Pelckmans, P. A., Bogers, J. J., Bult, H., De Man, J. G., Oosterbosch, L., Herman, A. G. and van Maercke, Y. M. (1991). Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J. Pharmacol. Exp. Ther. 256,441 -447.[Abstract]
Buchan, A. M. J. (1986). An immunocytochemical study of regulatory peptides in the amphibian gastrointestinal tract. Can. J. Zool. 64,1 -7.
Chartrel, N., Tonon, M. C., Vaudry, H. and Conlon, J. M. (1991). Primary structure and biological activity of pituitary adenylate cyclaseactivating polypeptide (PACAP) from frog brain. Endocrinology 129,3367 -3371.[Abstract]
Costa, M., Furness, J. B., Pompolo, S., Brookes, S. J. H., Bornstein, J. C., Bredt, D. S. and Snyder, S. H. (1992). Projections and chemical coding of neurons with immunoreactivity for nitric oxide synthase in the guinea-pig small intestine. Neurosci. Lett. 148,121 -125.[Medline]
Costa, M., Brookes, S. J. H., Steele, P. A., Gibbins, I., Burcher, E. and Kandiah, C. J. (1996). Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience 75,949 -967.[Medline]
D'Amato, M., Curro, D. and Montuschi, P. (1992). Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the gastric fundus: role of endogenous nitric oxide and vasoactive intestinal polypeptide. J. Auton. Nerv. Syst. 37,175 -186.[Medline]
Daniel, E. E., Haugh, C., Woskowska, Z., Cipris, S., Jury, J.
and Fox-Threlkeld, J. E. T. (1994). Role of nitric
oxide-related inhibition in intestinal function: relation to vasoactive
intestinal polypeptide. Am. J. Physiol.
266,G31
-G39.
Ekblad, E. and Sundler, F. (1997). Distinct receptors mediate pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptideinduced relaxation of the rat ileal longitudinal muscle. Eur. J. Pharmacol. 334, 61-66.[Medline]
Furness, J. B., Trusell, D. C., Pompolo, S., Bornstein, J. C., Maley, B. E. and Storm-Mathisen, J. (1989). Shapes and projection of neurons with immunoreactivity for gamma-aminobutyric acid in the guinea-pig small intestine. Cell Tissue Res. 256,293 -301.[Medline]
Gabriel, A. and Eckert, M. (1989). Demonstration of GABA-like immunoreactivity in the myenteric plexus of frog stomach. Histochemistry 91,523 -525.[Medline]
Glasgow, I., Mattar, K. and Krantis, A. (1998).
Rat gastroduodenal motility in vivo: involvement of NO and ATP in spontaneous
motor activity. Am. J. Physiol.
275,G889
-G896.
Grider, J. R. (1993). Interplay of VIP and
nitric oxide in regulation of the descending relaxation phase of peristalsis.
Am. J. Physiol. 264,G334
-G340.
Grider, J. R. and Jin, J. G. (1993). Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 54,521 -526.[Medline]
Grider, J. R., Katsoulis, S., Schmidt, W. E. and Jin, J. G. (1994). Regulation of the descending relaxation phase of intestinal peristalsis by PACAP. J. Auton. Nerv. Syst. 50,151 -159.[Medline]
Grider, J. R. and Makhlouf, G. M. (1992).
Enteric GABA: mode of action and role in the regulation of the peristaltic
reflex. Am. J. Physiol.
262,G690
-G694.
Harmar, A., Arimura, A., Gozes, I., Journot, L., Laburthe, M.,
Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S.
P., Wank, S. A. and Waschek, J. A. (1998). International
Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive
intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Pharmacol. Rev. 50,265
-270.
Hills, J. M., Jessen, K. R. and Mirsky, R. (1987). An immunohistochemical study of the distribution of the enteric GABA-containing neurons in the rat and guinea-pig intestine. Neuroscience 22,301 -312.[Medline]
Hoyle, C. H. V. (1998). Neuropeptide families: evolutionary perspectives. Regul. Pept. 73, 1-33.[Medline]
Jensen, J. and Holmgren, S. (1994). The gastrointestinal canal. In Comparative Physiology and Evolution of the Autonomic Nervous System (ed. S. Nilsson and S. Holmgren), pp. 119-167. Chur, Switzerland: Harwood Academic Publisher.
Jin, J. G., Murthy, K. S., Grider, J. R. and Makhlouf, G. M.
(1993). Activation of distinct cAMP- and cGMP-dependent pathways
by relaxant agents in isolated gastric muscle cells. Am. J.
Physiol. 264,G470
-G477.
Johansson, K. U. I. and Carlberg, M. (1995). NO-synthase: What can research on invertebrates add to what is already known? Adv. Neuroimmunol. 5,431 -442.[Medline]
Krantis, A., Costa, M., Furness, J. B. and Orbach, J.
(1980). -aminobutyric acid stimulates intrinsic inhibitory
and excitatory nerves in the guinea-pig intestine. Eur. J.
Pharmacol. 67,461
-468.[Medline]
Krantis, A., Mattar, K. and Glasgow, I. (1998).
Rat gastroduodenal motility in vivo: interactions of GABA and VIP control of
spontaneous relaxations. Am. J. Physiol.
275,G897
-G903.
Li, C. G. and Rand, M. J. (1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol. 191,303 -309.[Medline]
Li, Z. S., Furness, J. B., Young, H. M. and Campbell, G. (1992). Nitric oxide synthase immunoactivity and NADPH-diaphorase enzyme activity in neurons of the gastrointestinal tract of the toad, Bufo marinus. Arch. Histol. Cytol. 55,333 -350.[Medline]
Li, Z. S., Murphy, S., Furness, J. B., Young, H. M. and Campbell, G. (1993). Relationships between nitric oxide synthase, vasoactive intestinal peptide and substance-P immunoreactivities in neurons of the amphibian intestine. J. Auton. Nerv. Syst. 44,197 -206.[Medline]
Li, Z. S., Young, H. M. and Furness, J. B. (1994). Nitric oxide synthase in neurons of the gastrointestinal tract of an avian species, Coturnix coturnix. J. Anat. 184,261 -272.[Medline]
Lincoln, J., Hoyle, C. H. V. and Burnstock, G. (1997). Nitric Oxide in Health and Disease. Cambridge, UK: Cambridge University Press.
Lockwood, A. R. (1967). Animal Body Fluids. Cambridge, UK: Cambridge University Press.
Minocha, A. and Galligan, J. J. (1993). Excitatory and inhibitory responses mediated by GABAA and GABAB receptors in guinea-pig distal colon. Eur. J. Pharmacol. 230,187 -193.[Medline]
Murphy, S., Li, Z. S., Furness, J. B. and Campbell, G. (1993). Projections of nitric oxide synthase- and peptide-containing neurons in the small and large intestines of the toad (Bufo marinus). J. Auton. Nerv. Syst. 46, 75-92.
Nichols, K., Staines, W., Wu, J. Y. and Krantis, A. (1995). Immunopositive GABAergic neural sites display nitric oxide synthase related NADPH diaphorase activity in the human colon. J. Auton. Nerv. Syst. 50,253 -262.[Medline]
Olsson, C. and Gibbins, I. (1999). Nitric oxide synthase in the gastrointestinal tract of the estuarine crocodile, Crocodylus porosus. Cell Tissue Res. 296,433 -437.[Medline]
Olsson, C. and Holmgren, S. (1994). Distribution of PACAP (pituitary adenylate cyclase-activating polypeptide)-like and helospectin-like peptides in the teleost gut. Cell Tissue Res. 277,539 -547.[Medline]
Olsson, C. and Holmgren, S. (2000). PACAP and
nitric oxide inhibit contractions in proximal intestine of the Atlantic cod,
Gadus morhua. J. Exp. Biol.
203,575
-583
Olsson, C. and Karila, P. (1995). Coexistence of NADPH-diaphorase and vasoactive intestinal polypeptide in the enteric nervous system of the Atlantic cod (Gadus morhua) and the spiny dogfish (Squalus acanthias). Cell Tissue Res. 280,297 -305.
Parker, D. S., Raufman, J. P., O'Donaghue, T. L., Bledsoe, M.,
Yoshida, H. and Pisano, J. J. (1984). Amino acid sequences of
helospectins, new members of the glucagon superfamily, found in the Gila
monster venom. J. Biol. Chem.
259,11751
-11755.
Prosser, C. L. (1995). Rhythmic electrical and
mechanical activity in stomach of toad and frog. Am. J.
Physiol. 269,G386
-G395.
Sundler, F., Ekblad, E., Absood, A., Håkanson, R., Köves, K. and Arimura, A. (1992). Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience 46,439 -454.[Medline]
Timmermans, J. P., Barbiers, M., Scheuermann, D. W., Bogers, J. J., Adriaensen, D., Fekete, E., Mayer, B., Van Marck, E. A. and De Groodt-Lasseel, M. H. A. (1994). Nitric oxide synthase immunoreactivity in the enteric nervous system of the developing human digestive tract. Cell Tissue Res. 275,235 -245.[Medline]
Ward, S. M., Xue, C., Shuttleworth, C. W., Bredt, D. S., Snyder,
S. H. and Sanders, K. M. (1992). NADPH diaphorase and nitric
oxide synthase colocalization in enteric neurons of canine proximal colon.
Am. J. Physiol. 263,G277
-G284.
Williamson, S., Pompolo, S. and Furness, J. B. (1996). GABA and nitric oxide synthase immunoreactivities are colocalized in a subset of inhibitory motor neurons of the guinea-pig small intestine. Cell Tissue Res. 284, 29-37.[Medline]
Wu, M., Timmermans, J. P. and Scheurermann, D. W. (1998). Distributional pattern and targets of GABA-containing neurons in the porcine small and large intestine. Eur. J. Morph. 36,133 -142.